And u can buy a decent Chinese made CPAP for a fraction of Resmed's. And the drop in share price for both RMD and FPH would suggested the assumption of success in treating cardiac failure was heavily built into the share prices before. Despite this I do remain optimistic in the short to medium term as the funds would generally buy back in as they believe there many blue chip biotech in this country.
And u can buy a decent Chinese made CPAP for a fraction of...
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
